CD86-based analysis enables observation of bona fide hematopoietic responses. Kanayama M, Izumi Y, Yamauchi Y, Kuroda S, et al. Blood 2020;136:1144-1154.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kanayama M, Izumi Y, Yamauchi Y, Kuroda S, et al. CD86-based analysis enables observation of bona fide hematopoietic responses. Blood 2020;136:1144-1154.
PMID: 32438398